Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2014

01-04-2014 | Original Paper

Increasing Quality of Life and Reducing HIV Burden: The PATH+ Intervention

Authors: Michael B. Blank, Michael Hennessy, Marlene M. Eisenberg

Published in: AIDS and Behavior | Issue 4/2014

Login to get access

Abstract

The heightened risk of persons with serious mental illness (SMI) to contract and transmit human immunodeficiency virus (HIV) is a public health problem. Our objective was test the effectiveness of a community-based advanced practice nurse intervention to promote adherence to HIV and psychiatric treatment regimens call Preventing AIDS Through Health for Positives (PATH+). We enrolled 238 HIV-positive subjects with SMI who were in treatment at community HIV provider agencies from 2004 to 2009. Participants in the intervention group were assigned an advanced practice nurse who provided community-based care management at a minimum of one visit/week and coordinated their medical and mental healthcare for 12 months. A parallel process latent growth curve model using three data points for biomarkers (baseline, 12 and 24 months) and five data points for health related quality of life (baseline, 3, 6, 12, and 24 months) showed moderate to excellent fit for modeling changes in CD4, viral load, and mental and physical SF-12 subscales. Results suggest that positive effects for PATH+ persisted at 24 months; 12 months after the intervention ended. This project demonstrates the effectiveness of a nurse-led, community-based, individually tailored adherence intervention. We demonstrated improved outcomes in individuals with HIV/SMI and regarding health-related quality of life and reductions in disease burden.
Literature
1.
Gottesman I, Groome CS. HIV/AIDS risks as a consequence of schizophrenia. Schizophr Bull. 1997;23(4):675–84.PubMedCrossRef
2.
Walkup J, Blank MB, Gonzalez JS, et al. The impact of mental health and substance abuse factors on HIV prevention and treatment. J Acquir Immune Defic Syndr. 2008;47:S15–9.PubMedCrossRef
3.
Blank MB, Eisenberg MM. HIV and mental illness: opportunities for prevention. Journal of prevention & intervention in the community. J Prev Interv. 2007;33(1–2):1–4.CrossRef
4.
Susser E, Valencia E, Conover S. Prevalence of HIV-infection among psychiatric patients in a New York City men’s shelter. Am J Public Health. 1993;83(4):568–70.PubMedCentralPubMedCrossRef
5.
Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occurrence of HIV and serious mental illness among medicaid recipients. Psychiatric services. 2002;53(7):868–73.PubMedCrossRef
6.
Himelhoch S, McCarthy JF, Ganoczy D, Medoff D, Dixon LB, Blow FC. Understanding associations between serious mental illness and HIV among patients in the VA health system. Psychiatr Serv. 2007;58(9):1165–72.PubMedCrossRef
7.
Rothbard A, Blank M, Staab J, et al. Previously undetected metabolic syndromes and infectious diseases among psychiatric inpatients. Psychiatr Serv. 2009;60(4):534–7.PubMedCrossRef
8.
Parry CD, Blank MB, Pithey AL. Responding to the threat of HIV among persons with mental illness and substance abuse. Curr Opin Psychiatr. 2007;20(3):235–41.
9.
Blank MB, Hanrahan NP, Fishbein M, et al. A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness. Psychiatr Serv. 2011;62(11):1318–24.PubMedCrossRef
10.
Walkup J, Blank MB, Gonzalez JS, et al. The impact of mental health and substance abuse factors on HIV prevention and treatment. J Acquir Immune Defic Syndr. 2008;47:S15–9.PubMedCrossRef
11.
Drake RE. Brief history, current status, and future place of assertive community treatment. Am J Orthopsychiatry. 1998;68(2):172–5.PubMedCrossRef
12.
Lee AK, Hanrahan NP, Aiken LH, Blank MB. Perceived facilitators and barriers to the implementation of an advanced practice: nursing intervention for HIV regimen adherence among the seriously mentally ill. J Psychiatr Ment Health Nurs. 2006;13(5):626–8.PubMedCrossRef
13.
Morgan BD, Rossi AP. Difficult-to-manage HIV/AIDS clients with psychiatric illness and substance abuse problems: a collaborative practice with psychiatric advanced practice nurses. J Assoc Nurses AIDS Care. 2007;18(6):77–84.PubMedCrossRef
14.
Kane CF, Blank MB. NPACT: enhancing programs of assertive community treatment for the seriously mentally Ill. Community Ment Health J. 2004;40(6):549–59.PubMedCrossRef
15.
Aiken L, Lake E, Semaan S, et al. Nurse practitioner managed care for persons with HIV infection. J Nurs Scholarsh. 1993;25(3):172–7.CrossRef
16.
Battaglioli-DeNero AM. Strategies for improving patient adherence to therapy and longterm patient outcomes. J Assoc Nurses AIDS Care. 2007;18(1 Suppl):S17–22.PubMedCrossRef
17.
18.
Blank MB, Eisenberg MM. Tailored treatment for HIV + persons with mental illness: the intervention cascade. J Acquir Immune Defic Syndr. 2013;63:S44–8.PubMedCrossRef
19.
Ware JE Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of Scales and Preliminary Tests of Reliability and Validity. Med Care. 1996;34(3):220–33.PubMedCrossRef
20.
Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J, Osher FC. Reliability and Validity of the SF-12 Health Survey among People with Severe Mental Illness. Med Care. 2000;38(11):1141–50.PubMedCrossRef
21.
Curran P, Hussong A. Structural equation modeling of repeated measures data: latent curve analysis. In: Moskowitz D, Hershberger S, editors. Modeling intraindividual variability with repeated measures data. Mahwah: Lawrence Erlbaum; 2002. p. 59–85.
22.
Curran P, Muthén B. The application of latent curve analysis to testing developmental theories in intervention research. Am J Community Psychol. 1999;27:567–95.PubMedCrossRef
23.
Fergus S, Zimmerman M, Caldwell CH. Growth trajectories of sexual risk behavior in adolescence and young adulthood. Am J Public Health. 2007;97:1096–101.PubMedCentralPubMedCrossRef
24.
Barnes G, Reifman A, Farrell M, Dintcheff B. The effects of parenting on the development of adolescent alcohol misuse: a six-wave latent growth model. J Marriage Family. 2000;62:175–86.CrossRef
25.
Fishbein M, Hennessy M, Kamb M, et al. Using intervention theory to model factors influencing behavior change. Project RESPECT. Eval Health Prof. 2001;24(4):363–84.PubMedCrossRef
26.
Bollen K, Curran P. Latent curve models. New York: Wiley; 2006.
27.
Cheong J, MacKinnon DP, Khoo ST. Investigation of mediational processes using parallel process latent growth curve modeling. Struct Equ Modeling. 2003;10(2):238–62.PubMedCentralPubMedCrossRef
28.
Biesanz J, Deeb-Sossa N, Papadakis A, Bollen K, Curran P. The role of coding time in estimating and interpreting growth curve models. Psychol Methods. 2004;9(1):30–52.PubMedCrossRef
29.
Hu L-T, Bentler P. Evaluating model fit. In: Hoyle R, editor. Structural equation modeling: Concepts, issues and applications. Newbury Park: Sage; 1995. p. 76–99.
30.
Koblin B, Chesney M, Coates T. Effects of a behavioral intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomized controlled study. Lancet. 2004;364:41–50.PubMedCrossRef
31.
Belcher L, Kalichman S, Topping M, et al. A randomized trial of a brief HIV risk reduction counseling intervention for women. J Consult Clin Psychol. 1998;66(5):856–61.PubMedCrossRef
32.
Cottler L, Compton W, Abdahllah A, Cunningham-Williams R, Abram F, Fichtenbaum C. Peer delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers. Public Health Rep. 1998;113:58–66.
33.
Stephens RC, Simpson DD, Coyle SL, McCoy CB. Comparative effectiveness of NADR interventions. In: Brown BS, Beschner GM, editors. Handbook on risk of AIDS. Westport: Greenwood Press; 1993. p. 519–56.
34.
Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol. 1995;142(8):864–74.PubMed
35.
Gibson DR, McCusker J, Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users. AIDS. 1998;12(8):919–29.PubMedCrossRef
36.
Coyle S, Needle R, Normand J. Outreach based HIV prevention for injecting drug users: a review of published outcome data. Public Health Rep. 1998;113(Supplement 1):19–30.PubMedCentralPubMed
37.
Lightfoot M, Rotheram-Borus MJ, Comulada S, Gundersen G, Reddy V. Self-monitoring of behaviour as a risk reduction strategy for persons living with HIV. AIDS Care. 2007;19(6):757–63.PubMedCrossRef
38.
Mannheimer SB, Morse E, Matts JP, et al. Sustained benefit from a long-term antiretroviral adherence intervention: results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006;43:S41–7.PubMedCrossRef
39.
Holzemer WL, Bakken S, Portillo CG. Testing a nurse-tailored HIV medication adherence intervention. Nurs Res. 2006;55:189–97.PubMedCrossRef
40.
Rotheram-Borus MJ, Swendeman D, Chovnick G. The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol. 2009;5:143.PubMedCentralPubMedCrossRef
41.
42.
Marziali M, De Santis W, Carello R, et al. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART. AIDS. 2006;20(16):2033–41.PubMedCrossRef
Metadata
Title
Increasing Quality of Life and Reducing HIV Burden: The PATH+ Intervention
Authors
Michael B. Blank
Michael Hennessy
Marlene M. Eisenberg
Publication date
01-04-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0606-x

Other articles of this Issue 4/2014

AIDS and Behavior 4/2014 Go to the issue

Original Paper

Pregnant Women Living with HIV (WLH) Supported at Clinics by Peer WLH: A Cluster Randomized Controlled Trial

Original Paper

Methadone Maintenance Therapy Decreases the Rate of Antiretroviral Therapy Discontinuation Among HIV-Positive Illicit Drug Users

Substantive Review

Identification of Evidence-Based Interventions for Promoting HIV Medication Adherence: Findings from a Systematic Review of U.S.-Based Studies, 1996–2011

Guest Editorial

Development of Year 2020 Goals for the National HIV/AIDS Strategy for the United States

Original Paper

Comparing Estimates of Multiple and Concurrent Partnerships Across Population Based Surveys: Implications for Combination HIV Prevention

Original Paper

The Use of Cell Phone Support for Non-adherent HIV-Infected Youth and Young Adults: An Initial Randomized and Controlled Intervention Trial
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits